MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Mibiomics
Mibiomics

Millions of people worldwide suffer from incurable skin disorders including psoriasis, atopic dermatitis and more. Current treatments may cause serious adverse events, are not effective enough, and are too expensive, especially for mild-moderate sufferers. Our unique therapeutic approach, balancing the dermal microbiome, reinstates the skin's natural resilience resulting in healthier, normal skin. Our mission is to develop innovative, safe and effective microbiome based drugs approved by FDA.
MIBIOMICS mission is to develop innovative, safe and effective microbiome based solutions to treat currently incurable skin diseases.

Connect with Mibiomics

2020

2020 Finalist Israel

Sub industry

Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.